Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Study to Provide Real World Data for A.I. Seizure Forecasts

Embrace2 smart watch

A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures. . . . → Read More: Study to Provide Real World Data for A.I. Seizure Forecasts

Organ Chip Devices to Model for Radiation Sickness

Organ on a chip

The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness. . . . → Read More: Organ Chip Devices to Model for Radiation Sickness

FDA Funds Study of Real World Data for Biosimilars

Medical gear

A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs. . . . → Read More: FDA Funds Study of Real World Data for Biosimilars

FDA Clears Genetic Cancer Risk Detection Test

DNA illustration

The Food and Drug Administration authorized marketing of a genetic test for detecting hundreds of gene variants associated with a higher risk of developing certain cancers. . . . → Read More: FDA Clears Genetic Cancer Risk Detection Test

FDA Clears Biotech Seasonal Flu Treatment Trial

3-D print of influenza virus

A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains. . . . → Read More: FDA Clears Biotech Seasonal Flu Treatment Trial

Small Biz Grant Supports Regenerative Alzheimer’s Treatment

Healthy neuron illustration

A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment

Autoimmune Neuro Disease Start-Up Raises $58M

Mental health graphic

A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M

FDA Issues Guidance for Opioid Therapy Device Trials

Ambulance at night

The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder. . . . → Read More: FDA Issues Guidance for Opioid Therapy Device Trials

Trial Cleared for Lab-Grown Replacement Knee Cartilage

Knee joint X-ray

A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage

Cancer Immunotherapy Biotech Issues $80M IPO

Wall Street sign

A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO